Your browser doesn't support javascript.
loading
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects.
Esfandiari, Ehsanollah; Chen, Mary; Smithson, Glennda; Blair, Derek; Faessel, Helene; Wagner, John; Mclean, Lachy; Fedyk, Eric R.
Afiliação
  • Esfandiari E; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Chen M; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Smithson G; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Blair D; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Faessel H; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Wagner J; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Mclean L; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
  • Fedyk ER; Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.
Clin Transl Sci ; 14(3): 820-828, 2021 05.
Article em En | MEDLINE | ID: mdl-33650758
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Basófilos / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Basófilos / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Idioma: En Ano de publicação: 2021 Tipo de documento: Article